Live Breaking News & Updates on Lupin Healthcare United
Stay updated with breaking news from Lupin healthcare united. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin Limited (Lupin) has announced the UK launch of Beclu® (beclometasone dipropionate) 100 micrograms (mcg) and 200 mcg pressurised metered dose inhalers (pMDI) for the treatment of mild, moderate or severe asthma.1,2 Beclu 100 is indicated for adults or . ....
Lupin's Namuscla® is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
FOR UK MEDICAL AND TRADE MEDIA ONLY Lupin's Namuscla (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM) Slough ....
Investegate announcements from Lupin Ltd, Lupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM) ....
Lupin receives UK marketing authorisation for Luforbec® 100/6 pMDI, first branded generic alternative to Fostair® to treat Asthma & COPD pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.